IDEXX Laboratories, Inc.

IDXX · Healthcare · · USD

535.38 USD

+0.00 (1.15%)

● Updated 2026-09-07 19:34 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score SELL Long-term (Investment)

/ 100

Technical 0

Trend & RS 19

Momentum 38

Fundamental 67

Macro 64

Liquidity 44

Component	Score	Weight
Technical	0.0	10%
Trend & RS	19.0	10%
Momentum	37.6	5%
Fundamental	66.7	40%
Macro	64.4	15%
Liquidity	44.4	20%

Trade Setup

Entry	535.38
Stop Loss	501.86 (6.3%)
Target 1 (1:1)	568.90 (+6.3%)
Target 2 (2:1)	602.42 (+12.5%)

ATR(14)	16.76 (3.1%)
Risk per Share	33.52
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	13.8	-1.45
Momentum	37.6	-0.50
Quality	63.1	+0.52
Composite	38.1

Quality Scores

Piotroski F-Score 6 /9 — Average

✓ ✓ ✗ ✗ ✓ ✗ ✓ ✓ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score Insufficient Data

Valuation vs Peers Overvalued

Metric	Stock	Sector	vs Peers
P/E Ratio	37.6	22.0	+71% above
P/B Ratio	26.2	4.0	Above

Comparing against Healthcare median multiples.

Trading at a premium to sector peers — verify growth justifies premium.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value

243.55

Market Price

535.38

Upside

-54.5%

Margin of Safety	-119.8%
Stage 1 PV (5yr FCF)	4,574,570,306
Terminal Value PV	14,612,794,383
Total Enterprise Value	19,187,364,689

Assumptions

Base FCF	897,474,497
Growth Rate (5yr)	9.7%
Terminal Growth	2.5%
Discount Rate (WACC)	9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%

Recommended Size

31.76%

Full Kelly

15.88%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 49/100. Estimated win rate 55%, avg win 7.9%, avg loss 4.0%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG SELL

Bullish Signals

Bearish Signals

41.35

RSI(14)

-6.9145

MACD

Relative Strength (RS) WEAK RS

/ 99

RS Rating

O'Neil filter: <80

RS vs SPY	↓ FALLING (-9.5% vs SPY 3M)
RS vs Sector	UNDERPERFORMING (Healthcare)
RS New High	No (61d since high)
Sector Outperformance	-12.5% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

WEAK RS: Underperformer — the stock is lagging the market. Avoid until RS trend reverses upward.

Technical Indicators

Indicator	Value	Signal
Rsi	41.35	NEUTRAL
Macd	-6.9145	BEARISH
Ma Cross	558.15 / 607.14	DEATH CROSS
Trend Short		BELOW SMA50
Trend Long		BELOW SMA200
Bollinger		MIDDLE
Volume	0.81x	NORMAL

Key Levels

Level	Price
52-Week High	769.98
Bollinger Upper	587.09
SMA(200)	607.14
SMA(50)	558.15
SMA(20)	555.19
Current Price	535.38
Bollinger Lower	523.29
52-Week Low	518.55
ATR(14)	16.76

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

ACCUMULATION E Confidence

50%

Acc: 1.0 | Dist: 1.0 | Markup: 0.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-08-31	Normal	1.39x	Normal bar — no special VSA pattern
2026-09-01	Normal	0.91x	Normal bar — no special VSA pattern
2026-09-02	Normal	1.31x	Normal bar — no special VSA pattern
2026-09-03	Normal	1.18x	Normal bar — no special VSA pattern
2026-09-04	Spring	0.81x	Price broke below support then recovered on low volume — potential reversal

Ichimoku Cloud BEARISH

Line	Value	Status
Tenkan-sen (9)	541.64	Below Kijun
Kijun-sen (26)	573.10	Base line
Senkou A	557.37	Leading span A
Senkou B	571.35	Leading span B
Cloud	557.37 – 571.35	Bearish (Red)
Price vs Cloud	535.38	Below Cloud
Chikou Span	559.07	Bearish
Alignment Score	0/4	BEARISH